Log In
Print this Print this

Bionect, 0.2% hyaluronic acid

  Manage Alerts
Collapse Summary General Information
Company Cipher Pharmaceuticals Inc.
DescriptionLow moleuclar weight formulation of hyaluronic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationDermatosis
Indication DetailsTreat skin irritation associated with radiation and chemotherapy
Regulatory Designation
PartnerMidatech Pharma plc;
Mission Pharmacal Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today